Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Graphite Bio, Inc. (GRPH)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 58,080,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Graphite Bio is a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases. Co.'s primary product candidate GPH101 is an approach with the potential to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. Co.'s pipeline also includes GPH102 for beta-thalassemia and GPH201 for X-linked severe combined immunodeficiency syndrome; GPH301 for Gaucher disease and an early-stage research program for alpha-1 antitrypsin deficiency; and various undisclosed programs in both hematopoietic stem cells and other cell types.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 998,009 998,009 998,009 1,427,473
Total Buy Value $15,000,075 $15,000,075 $15,000,075 $16,751,193
Total People Bought 1 1 1 3
Total Buy Transactions 1 1 1 4
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 45
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mccollum James W Director   –       •      –    2024-03-21 4 A $0.00 $249,992 I/I 494,233 494,233     -
   Mccollum James W Director   –       •      –    2024-03-21 4 A $0.00 $0 D/D 95,034 95,034     -
   Shah Rajeev M. Director   –       •       •   2024-03-21 4 B $15.03 $15,000,075 I/I 998,009 694,755 2.25     -
   Shah Rajeev M. Director   –       •       •   2024-03-21 4 A $0.00 $0 I/I 3,245,785 164,729     -
   Versant Ventures Vii Gp-Gp, Llc   –       –       •   2024-03-21 4 A $0.00 $0 I/I 598,203 842,162     -
   Odrich Marc Chief Medical Officer   •       –      –    2024-03-21 4 A $0.00 $0 D/D 99,599 99,599     -
   Akkaraju Srinivas 10% Owner   –       –       •   2022-04-12 4 B $4.08 $1,428,000 I/I 350,000 8,459,314 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2022-04-11 4 B $4.07 $303,068 I/I 74,464 8,109,314 1.5     -
   Gutry Phil CHIEF BUSINESS OFFICER   •       –      –    2022-04-11 4 B $4.01 $20,050 D/D 5,000 299,941 2.74     -
   Akkaraju Srinivas 10% Owner   –       –       •   2022-01-24 4 B $8.70 $200,100 I/I 23,000 8,034,850 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2022-01-21 4 B $8.99 $899,000 I/I 100,000 8,011,850 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2022-01-20 4 B $8.92 $384,497 I/I 43,105 7,911,850 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2022-01-19 4 B $9.24 $504,181 I/I 54,565 7,868,745 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2021-12-15 4 B $10.19 $227,533 I/I 22,329 7,814,180 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2021-10-15 4 B $12.49 $28,727 I/I 2,300 7,590,166 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2021-10-14 4 B $12.50 $38,750 I/I 3,100 7,587,866 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2021-10-13 4 B $13.22 $600,188 I/I 45,400 7,584,766 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2021-10-08 4 B $13.12 $984,000 I/I 75,000 7,539,366 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2021-10-07 4 B $14.94 $134,774 I/I 9,021 7,464,366 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2021-10-06 4 B $13.83 $850,199 I/I 61,475 7,455,345 1.5     -
   Gutry Phil CHIEF BUSINESS OFFICER   •       –      –    2021-06-29 4 A $0.00 $0 D/D 8,126 293,471     -
   Versant Vantage Ii Gp-Gp, Llc 10% Owner   –       –       •   2021-06-29 4 B $17.00 $3,060,000 I/I 180,000 1,707,719 1.5     -
   Versant Vantage Ii Gp-Gp, Llc 10% Owner   –       –       •   2021-06-29 4 A $0.00 $0 I/I 1,527,719 1,527,719     -
   Versant Vantage Ii Gp-Gp, Llc 10% Owner   –       –       •   2021-06-29 4 A $0.00 $0 D/D 12,343,727 14,708,398     -
   Shah Smital Director   –       •      –    2021-06-29 4 B $17.00 $99,994 I/I 5,882 5,882 2.1     -

  45 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed